Status: Recruiting
ONO-4059 Study in Patients With Steroid-resistant Pemphigus
ONO-4059-10:Multicenter, placebo-controlled, randomized, double-blind, Phase 3 study in patients with steroid-resistant pemphigus
Participants needed: 34
Trial details
Phase: Phase 3Age: 20+Biological sex: AllType: InterventionalSponsor: Ono Pharmaceutical Co., Ltd.Updated: Jan 7, 2026Locations: 25
Eligibility criteria
Patients with a diagnosis of pemphigus [+1]
Patients with an active infection [+2]